Sign in

CIK 0000886163

  • Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
770160744
Phone
+1 858-550-7500
Business address
7111 FAIRWAY DRIVE, SUITE 302, PALM BEACH GARDENS, FL, 33418
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
  1. 4 Shares withheld for taxes Director gave up 182 shares (to pay taxes)
  2. 4 Grant or award Director acquired 836 shares (grant or award)
  3. 4 Grant or award Director acquired 836 shares (grant or award)
  4. 4 Grant or award Director acquired 836 shares (grant or award)
  5. 4 Grant or award Director acquired 836 shares (grant or award)
  6. 4 Grant or award Director acquired 836 shares (grant or award)
  7. 4 Planned sale CLO & Secretary sold 5,000 shares at an average $227.06 ($1,135,316)
  8. 4 Exercise or conversion Chief Financial Officer acquired 1,736 shares (option exercise)
  9. 4 Planned sale Director sold 2,501 shares at an average $225.14 ($563,080)
  10. 4 Planned sale CLO & Secretary sold 5,000 shares at an average $231.31 ($1,156,556)
  11. 4 Planned sale Director sold 467 shares at an average $202.23 ($94,440)
  12. 4 Planned sale CLO & Secretary sold 5,000 shares at an average $201.24 ($1,006,224)
  13. 4 Open-market sale Director sold 2,161 shares at $200.76 ($433,842)
  14. 4 Grant or award Chief Financial Officer acquired 4,933 shares (grant or award)
  15. 4 Grant or award Chief Executive Officer acquired 10,495 shares (grant or award)
  16. 4 Grant or award CLO & Secretary acquired 4,513 shares (grant or award)
  17. 4 Open-market sale Director sold 1,000 shares at $207.87 ($207,873)
  18. 4 Planned sale Chief Financial Officer sold 3,057 shares at $225.00 ($687,825)
  19. 4 Planned sale CLO & Secretary sold 5,000 shares at an average $206.35 ($1,031,770)
  20. 4 Planned sale Chief Financial Officer sold 13,423 shares at an average $205.83 ($2,762,822)

Page 2 of 51 · 1,001 filings